Gofen & Glossberg LLC Cybin Inc. Transaction History

Gofen & Glossberg LLC

  • $3.89 Billion
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022
SELL
$0.74 - $1.22 $29,600 - $48,800
-40,000 Closed
0 $0
Q4 2021

Jan 25, 2022
BUY
$1.13 - $2.31 $16,950 - $34,650
15,000 Added 60.0%
40,000 $48,000
Q2 2021

Jul 13, 2021
BUY
$1.13 - $2.35 $28,249 - $58,750
25,000 New
25,000 $51,000

Others Institutions Holding CYBN

# of Institutions
11
Shares Held
185K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $2.07B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email